Health
Sacramento selected as COVID-19 vaccine trial site – KCRA Sacramento
Sacramento has been selected as a site for a COVID-19 vaccine trial. Both UC Davis Medical Center and Kaiser Permanente are participating in the vaccine trial through a partnership with Pfizer.
SACRAMENTO, Calif. —Sacramento has been selected as a site for a COVID-19 vaccine trial. Both UC Davis Medical Center and Kaiser Permanente are participating in the vaccine trial through a partnership with Pfizer.
The trial will span 120 locations with a goal of including 30,000 applicants worldwide.
What we want the community to know is that this is really important research. Its a first step in developing a vaccine for COVID, UC Davis Medical School Dean Allison Brashear said.
UC Davis Me…
-
Noosa News23 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News22 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
General20 hours agoDairy farmers devastated by floods across parts of New South Wales
-
General23 hours ago‘Aussie Cossack’ Simeon Boikov’s legal fees paid by fund linked to Russian intelligence